drugset / Trial / NCT02017236
A Food Effect Phase I Study of the Volitinib in Healthy Subjects
RandomizedCrossoverOpen-labelHealth-services research
Summary
The purpose of this study is to evaluate to determine the effect of food on the PK of a single dose of 600 mg Volitinib and its two major metabolites in healthy subjects.
Timeline
- Start
- 2013-11
- Primary completion
- 2014-03
- Completion
- 2014-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Savolitinib | Small molecule | 600 mg | Oral |
Indications
No indication recorded.